Statins are lipid-lowering drugs that are widely used for treating hyperlipidemia, especially in diabetic patients. The aim of our study was to explore the effects of atorvastatin on oxidative stress and apoptosis in the sciatic nerve due to hyperglycemia. Diabetes was induced by streptozotocin. Atorvastatin was given orally for two weeks beginning from the sixth week. Microscopic examination of sciatic nerve revealed that normal tissue organization was disrupted in streptozotocin induced diabetic rats. Treatment with Atorvastatin reduced the histological damage and protected the morphological integrity of the sciatic nerve in streptozotocin induced diabetes. Increased expressions of transforming growth factor beta-1, endothelial nitric oxi...
Increased reactive oxygen species by the activation of NADPH oxidase (NOX) contributes to the develo...
Objectives: The aim of this study is to evaluate the effect of Valproic acid in diabetic neuropathy....
Simvastatin is a hypocholesterolemic agent presumed to cause peripheral neuropathy. We arranged an e...
Statins are lipid-lowering drugs that are widely used for treating hyperlipidemia, especially in dia...
Vascular defects contribute substantially to neuropathic changes associated with metabolic abnormali...
Oxidative stress induces nerve damage in type 2 diabetes mellitus and leads to diabetic polyneuropat...
Rats with streptozotocin-induced diabetes have a decreased rate of sciatic nerve regeneration. We st...
Elevated plasma lipids contribute to neurovascular dysfunction in diabetes. Statins have lipid-lower...
doi:10.7555/JBR.26.20110054 Diabetic neuropathies are a family of nerve disorders caused by diabetes...
This study aimed to evaluate the effects of ursolic acid, hyperinsulinemia and vitamin B complex on ...
Aims. To investigate the candidate biomarkers and molecular mechanisms involved in the early phase o...
This study points out the early alterations that affect the sciatic nerve of rats with experimentall...
Despite extensive research, the etiology of diabetic neuropathy remains unclear. Several key metabol...
Introduction: Without affecting the lipid profile, a low-dose treatment with atorvastatin contribute...
Background: Diabetic neuropathy affects 50%–66% of patients with diabetes mellitus. Oxidative stress...
Increased reactive oxygen species by the activation of NADPH oxidase (NOX) contributes to the develo...
Objectives: The aim of this study is to evaluate the effect of Valproic acid in diabetic neuropathy....
Simvastatin is a hypocholesterolemic agent presumed to cause peripheral neuropathy. We arranged an e...
Statins are lipid-lowering drugs that are widely used for treating hyperlipidemia, especially in dia...
Vascular defects contribute substantially to neuropathic changes associated with metabolic abnormali...
Oxidative stress induces nerve damage in type 2 diabetes mellitus and leads to diabetic polyneuropat...
Rats with streptozotocin-induced diabetes have a decreased rate of sciatic nerve regeneration. We st...
Elevated plasma lipids contribute to neurovascular dysfunction in diabetes. Statins have lipid-lower...
doi:10.7555/JBR.26.20110054 Diabetic neuropathies are a family of nerve disorders caused by diabetes...
This study aimed to evaluate the effects of ursolic acid, hyperinsulinemia and vitamin B complex on ...
Aims. To investigate the candidate biomarkers and molecular mechanisms involved in the early phase o...
This study points out the early alterations that affect the sciatic nerve of rats with experimentall...
Despite extensive research, the etiology of diabetic neuropathy remains unclear. Several key metabol...
Introduction: Without affecting the lipid profile, a low-dose treatment with atorvastatin contribute...
Background: Diabetic neuropathy affects 50%–66% of patients with diabetes mellitus. Oxidative stress...
Increased reactive oxygen species by the activation of NADPH oxidase (NOX) contributes to the develo...
Objectives: The aim of this study is to evaluate the effect of Valproic acid in diabetic neuropathy....
Simvastatin is a hypocholesterolemic agent presumed to cause peripheral neuropathy. We arranged an e...